Follow The Filings

ASBP Aspire Biopharma

Aspire Biopharma earnings company data as of 4:45 AM ET 11/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 20 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K/A 1.01,9.01
8-K 4.01,9.01
8-K 5.03,8.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
10-Q
SCHEDULE 13G —
8-K 1.01,2.03,3.02,7.01,9.01
SCHEDULE 13G/A —
8-K 8.01
SCHEDULE 13G —
8-K 5.07
8-K 1.01,7.01,9.01
8-K 8.01
SCHEDULE 13G —
10-Q
8-K 5.03,9.01
SCHEDULE 13G/A —
DEF 14A
8-K 7.01,9.01
8-K/A 1.01,5.03,9.01
8-K 7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf